Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Related Articles
Commentaries
MAKE A COMMENT
All fields requiredMore Views
- Founder of sport parachuting in Cuba passes away
- New Freedom Flotilla to set sail for Gaza in defiance of Israel's naval blockade
- Venezuela rejects U.S. claim to protect its oil industry
- Thousands march through the streets of Madrid to demand Spain stop arms sales to apartheid Israel
- Cuba begins 63rd anti-polio vaccination campaign